Friday, 1 July 2011

Decadron




In the US, Decadron (dexamethasone systemic) is a member of the drug class glucocorticoids and is used to treat Addison's Disease, Adrenal Insufficiency, Adrenocortical Insufficiency, Adrenogenital Syndrome, Ankylosing Spondylitis, Aspiration Pneumonia, Asthma, Asthma - acute, Atopic Dermatitis, Bursitis, Cerebral Edema, Chorioretinitis, Croup, Cushing's Syndrome, Dermatitis Herpetiformis, Eczema, Epicondylitis - Tennis Elbow, Erythroblastopenia, Evan's Syndrome, Gouty Arthritis, Hay Fever, Hemolytic Anemia, Hypercalcemia of Malignancy, Idiopathic Thrombocytopenic Purpura, Inflammatory Conditions, Iridocyclitis, Iritis, Juvenile Rheumatoid Arthritis, Keratitis, Leukemia, Loeffler's Syndrome, Lymphoma, Meningitis - Haemophilus influenzae, Meningitis - Listeriosis, Meningitis - Meningococcal, Meningitis - Pneumococcal, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nausea/Vomiting - Chemotherapy Induced, Neurosarcoidosis, Pemphigus, Psoriatic Arthritis, Pulmonary Tuberculosis, Rheumatoid Arthritis, Sarcoidosis, Seborrheic Dermatitis, Shock, Synovitis, Systemic Lupus Erythematosus, Thrombocytopenia, Toxic Epidermal Necrolysis, Tuberculous Meningitis, Ulcerative Colitis and Uveitis - Posterior.

US matches:

  • Decadron

  • Decadron Dose Pack Tablets (Dose Pack)

  • Decadron Ocumeter

Ingredient matches for Decadron



Dexamethasone

Dexamethasone is reported as an ingredient of Decadron in the following countries:


  • Argentina

  • Brazil

  • Egypt

  • Greece

  • Italy

  • Japan

  • Luxembourg

  • Peru

  • Portugal

  • Taiwan

  • United States

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Decadron in the following countries:


  • Argentina

  • Brazil

  • Bulgaria

  • Colombia

  • Egypt

  • Greece

  • Italy

  • Japan

  • Oman

Dexamethasone 21-acetate (a derivative of Dexamethasone) is reported as an ingredient of Decadron in the following countries:


  • Argentina

International Drug Name Search

No comments:

Post a Comment